Flexall Ultra (Extra Strength)
Natural health product licensed in Canada
- Licence holder
- Opella Canada Inc.
- NPN or DIN-HM
- 02230867
- Status
- Inactive licence
- Licence date
- 5 October 2007
- Revision date
- Not provided
- Form
- Gel
- Route of administration
- Topique
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Mentha piperita, Steareth 2, Diisopropyl Adipate, Salicylate de méthyle, Jus de feuilles d'Aloe Barbadensis, SD Alcohol 40-A, Allantoïne, Eucalyptus globulus, Eau, acétate de tocophéryle, triéthanolamine, Carbomère, Glycérine, Extrait de thymus vulgaris (thym), Steareth 21
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 2 years | Not specified | maximum: 4 Tous les jours |
| Adultes | Not specified | Not specified | maximum: 4 Tous les jours |
Uses authorised in Canada
For the temporarily relieves of aches and pains of muscles and joints associated with backache, lumbago, strains, bruises, sprains and arthritic or rheumatic pain.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 02230867
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.